Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenue		$ 3,093
Operating expenses:
Direct expenses	8,766	4,902
Research and development	2,500
Sales and marketing	308	541
General and administrative	574,955	131,361
Total operating expenses	586,529	136,804
Operating loss	(586,529)	(133,711)
Other (expenses) income:
Interest expense	(21,740)	(98,192)
Change in fair value of derivative liability	(21,143)	3,549
Change in fair value of warrant liability	(278,630)	101,993
Loss on conversion of related party debt into common stock	(10,604,620)
Loss on conversion of trade payables into common stock	(993,715)
Loss on conversion of Series A preferred stock into common stock	(1,735,500)
Gain on settlement of accounts payable for Series B preferred stock	211,600
Total other (expenses) income	(13,443,748)	7,350
Loss before provision for income taxes	(14,030,277)	(126,361)
Net loss	$ (14,030,277)	$ (126,361)
Net loss per share- basic and diluted (in Dollars per share)	$ (0.02)	$ 0.00
Weighted average shares outstanding basic and diluted (in Shares)	690,048,665	111,131,373